abstract |
The disclosure is generally directed to a neuroactive 19-alkoxy-17-substituted steroid as referred to herein for use, for example, as an anesthetic and / or for the treatment of disorders related to GABA function and activity, ≪ / RTI > The present disclosure further relates to pharmaceutical compositions comprising such compounds. |